Ireland

--:--IST

Latest

Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide

Subscribe

Registers› Irish medicines ›Ipsen Pharma

Medicines register · Ireland

Ipsen Pharma — licensed medicines

21 medicines held by Ipsen Pharma on the Irish market, from the HPRA register.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,336 authorised products are in this register. Synced 20 Sep 2026, 17:51 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Alluzience, 200 Speywood units/mL, solution for injection PA1613/004/001

Botulinum Toxin A - Haemagglutinin Complex

Marketed

Azzalure, 125 Speywood units, powder for solution for injection PA1613/001/001

Clostridium botulinum toxin type a haemagglutinin complex

Marketed

Bylvay 1 200 micrograms hard capsules EU/1/21/1566/004

Odevixibat sesquihydrate

—

Bylvay 200 micrograms hard capsules EU/1/21/1566/001

Odevixibat sesquihydrate

—

Bylvay 400 micrograms hard capsules EU/1/21/1566/002

Odevixibat sesquihydrate

—

Bylvay 600 micrograms hard capsules EU/1/21/1566/003

Odevixibat sesquihydrate

—

CABOMETYX 20 mg film-coated tablets EU/1/16/1136/001-002

Cabozantinib

—

CABOMETYX 40 mg film-coated tablets EU/1/16/1136/003-004

Cabozantinib

—

CABOMETYX 60 mg film-coated tablets EU/1/16/1136/005-006

Cabozantinib

—

COMETRIQ 20 mg hard capsules EU/1/13/890/001

Cabozantinib (s)-malate

—

COMETRIQ 80 mg hard capsules EU/1/13/890/002-003

Cabozantinib (s)-malate

—

Dysport 300 units Powder for solution for injection PA1613/002/002

Botulinum toxin type A - haemagglutinin complex

Marketed

Dysport 500 units Powder for solution for injection PA1613/002/001

Clostridium botulinum toxin type a haemagglutinin complex

Marketed

Iqirvo 80 mg film-coated tablets EU/1/24/1855/001

Elafibranor

—

KAYFANDA 1200 microgram hard capsules EU/1/24/1854/004

Odevixibat

—

KAYFANDA 200 microgram hard capsules EU/1/24/1854/001

Odevixibat

—

KAYFANDA 400 microgram hard capsules EU/1/24/1854/002

Odevixibat

—

KAYFANDA 600 microgram hard capsules EU/1/24/1854/003

Odevixibat

—

NutropinAq 10 mg/2 ml solution for injection EU/1/00/164/003-004

Somatropin

—

NutropinAq 10 mg/2 ml solution for injection EU/1/00/164/005

Somatropin

—

Relfydess, 100 units/mL, solution for injection PA1613/005/001

Botulinum Toxin Type A

Marketed

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 3 October 2026. https://priyalifescience.com/medicines/company/ipsen-pharma

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.